Application 022008
- Type
- NDA
- Sponsor
- GLAXOSMITHKLINE LLC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 2MG BASE | Yes | Yes |
| 002 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 003 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 4MG BASE | Yes | No |
| 004 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 8MG BASE | Yes | No |
| 005 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 12MG BASE | Yes | No |
| 006 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 6MG BASE | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0007-4882 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4882 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4883 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4883 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4885 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4887 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4887 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4888 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4888 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |